Malaysia’s Immunitee Health Passport Accepted Into Singapore


Qualitas Medical Group has spearheaded the nation’s efforts in Covid-19 screening through on-site screening, walk-in clinics and home sampling. These efforts have contributed immensely in curbing the spread of COVID-19 and has been recognised by the Ministry of Health and other regulatory bodies, like Social Security Organisation (SOCSO).

In line with the government’s effort in fighting COVID-19, Qualitas has increased its capacity and capability in conducting COVID-19 Screening Services. Qualitas in collaboration with Socso under the Program Saringan Prihatin (PSP) initiative has established a Public-Private Initiative (PPI) called Aggregated Screening Centre (ASC).

The objective of the ASC is to provide a one-stop-centre for all eligible foreign workers (FW), who are considered high-risk in the COVID-19 transmission chain, to undergo RTK-Antigen screening procedure in accordance with Standard Operating Procedure (SOP) outlined by the Ministry of Health Malaysia (MOH). Socso will subsidise the cost of RTK-Ag, which is to be utilised via clinics for all eligible Foreign Workers.

It is hoped that through this programme, there will be further participation of foreign workers especially from SMEs, and contribute significantly to breaking the transmission chain of the COVID-19 in more proactive and efficient ways.

Malaysia’s Immunitee Health Passport has partnered with Temasek-founded Affinidi to become Malaysia’s first Health Passport to be accepted into Singapore. Immunitee’s clinical partner is Qualitas Medical Group, the primary healthcare provider in Malaysia as well as across the Asia-Pacific region with a network of more than 250 clinics.

Immunitee also works with laboratory partners Clinipath and Gribbles, Malaysia’s most trusted providers of diagnostic laboratory services.

Scheduled to launch in March 2021, Immunitee will be provided as an open-source system at no charge to governments and organisations around the world.


Please enter your comment!
Please enter your name here